Daiwa Securities Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-405
Closed -$2K 1238
2019
Q1
$2K Hold
405
﹤0.01% 1153
2018
Q4
$1K Hold
405
﹤0.01% 1142
2018
Q3
$4K Hold
405
﹤0.01% 1099
2018
Q2
$3K Hold
405
﹤0.01% 1132
2018
Q1
$2K Buy
+405
New +$3.34K ﹤0.01% 1141

Other funds holding INSY

Daiwa Securities Group's INSY Position: Q2 2019 in Review

Daiwa Securities Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 405 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in INSY in Q1 2018 and held it in 5 quarters. The position peaked at $4K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Daiwa Securities Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 405 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $2K.
  • Daiwa Securities Group first reported a position in Insys Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
  • Daiwa Securities Group's Insys Therapeutics, Inc. position peaked at $4K in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Daiwa Securities Group's 13F filing for Q2 2019, filed 24 Jul 2019.